- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | XtalPi's AI biologics discovery platform licensed to Janssen Biotech | ||
| Fr | Activist investor Starboard cries foul play in exec U-turn at Pfizer | ||
| Fr | Booster Therapeutics to develop proteasome activator medicines | ||
| Fr | KeyBioscience and Eli Lilly extend partnership for obesity treatments | ||
| Fr | CPHI Milan: Targeting supply chain bottlenecks key for cell and gene therapies | ||
| Fr | CPHI Europe: Overcoming the unique challenges with high-concentration mAbs | ||
| Do | Bluebird bio's Skysona led to seven cases of blood cancer in gene therapy trials | ||
| Do | Paediatric type 2 diabetes faces significant underdiagnosis in China | ||
| Do | Biogen scores breakthrough status for anti-rejection transplant medication | ||
| Do | Lilly and insitro team up to develop AI-powered siRNA metabolic drugs | ||
| Do | England witnesses sharp rise in food allergy incidence | ||
| Do | Merck KGaA unveils €290m biosafety testing facility in Maryland, US | ||
| Do | CPHI Europe: Gummies as a drug delivery system could improve compliance | ||
| Do | Arda Therapeutics secures $43m to develop cell depletion therapies | ||
| Do | Pharmaceutical Technology Excellence Awards 2024: EMIS | ||
| Do | Boehringer and Circle Pharma link to develop new cancer treatment | ||
| 09.10. | Anima Biotech's machine learning programme 'reveals new mRNA drug targets' | ||
| 09.10. | MSD ventures into fibroblast therapies with $1.9bn deal with Mestag | ||
| 09.10. | Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says | ||
| 09.10. | Could preventative care save the future of the NHS? | ||
| 09.10. | FDA declines to approve Zealand Pharma's hypoglycaemia therapy in infants | ||
| 09.10. | Purespring secures $105m to start Phase I/II trial of IgAN gene therapy | ||
| 09.10. | Clinical Dose Companies in Contract Manufacturing for the Pharmaceutical Industry | ||
| 09.10. | City Therapeutics launches with $135m Series A funding | ||
| 09.10. | Ipsen's Elafibranor gains MHRA approval for PBC treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
